Gottlieb, Alice B., April W. Armstrong, Joseph F. Merola, Andrew Napoli, Miroslawa Nowak, Subhashis Banerjee, Thomas Lehman, and Philip J. Mease. “Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients With Active Psoriatic Arthritis: Results from a Phase 2 Trial”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s383. Accessed September 20, 2024. https://dermsquared.com/skin/article/view/2678.